Search results for: France
Filter search results
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
…in a selection of industrialised countries: Australia, Canada, France, Scotland, and the United Kingdom (England and Wales). The aims of the study are to identify the key determinants of decisions…
Patient preferences for treatment in relapsed/refractory acute leukemia
23 October 2025
Share this: Download publication David Mott Hannah Hussain Jake Hitch Sulayman Chowdhury Samantha Nier Chris Skedgel Key takeaways Across all five countries studied (UK, USA, France, Germany, and Italy), the…
Altering the trajectory of HIV in Europe
22 May 2025
…to rise, leading to increases in healthcare costs and broader societal impact. The total estimated cost of HIV care between 2025 and 2030 is estimated at €56.7bn across France, Germany,…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…often overlooked. Countries with more flexible HTA frameworks, like Canada and the UK, are better positioned to capture these broader value elements than others like Germany and France. Stakeholder collaboration…
Atherosclerotic cardiovascular disease (ASCVD) costs the world $680 billion a year in healthcare – roughly the size of Sweden’s entire economy, new research finds
31 March 2026
…insights into the health and economic costs of ASCVD across nine more-developed countries – the US, Canada, UK, Netherlands, France, Germany, Spain, Italy, and Japan. The researchers found that total costs associated with ASCVD range…
Are Recommendations for HTA of Gene Therapies Being Achieved?
11 September 2023
…develop country scorecards exploring the extent to which these recommendations are being achieved in eleven countries. The countries considered were: Australia, Canada, Denmark, England, France, Germany, Italy, the Netherlands, Spain,…
The Life Cycle of Pharmaceuticals: A Cross-National Perspective
1 April 2002
…contribution to the methodology of cross-national comparisons for medicines. In this study we use comprehensive data on outpatient sales for all drugs in seven countries (Canada, France, Germany, Italy, Japan,…
Pharmaceuticals in seven nations
1 May 1985
…pharmaceutical industry, with particular reference to its structure and activities in seven countries – the Federal Republic of Germany, France, Italy, Japan, Switzerland, the United Kingdom and the United States….
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
1 January 2022
…(HTA) agency determines how these challenges are currently addressed. This report provides an analysis of HTA agency assessments and reimbursement decisions for entrectinib and larotrectinib across England, Germany, France, Canada,…